Impact of Medications on COVID-19 Outcomes in Inflammatory Bowel Disease: Analysis of More Than 6000 Patients From an International Registry

Overview of attention for article published in Gastroenterology, September 2021

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (93rd percentile)
Good Attention Score compared to outputs of the same age and source (75th percentile)

Mentioned by

news: 1 news outlet
twitter: 31 X users

guideline: 1 clinical guideline source

Readers on

mendeley: 56 Mendeley

So far, Altmetric has seen 36 X posts from 31 X users, with an upper bound of 144,384 followers.

5) We know patients with IBD are not at increased risk for COVID-19 even in the pre-vaccine era. https://t.co/50IGUe7t55

@ccjapan1 SECURE-IBDの論文，２報目まで見た記憶があるのですが，これは知りませんでした．これから見ますが，すごい規模になってますね．．　https://t.co/miS2EWXYdH

@RocioInOC @CrohnsColitisFn @AmCollegeGastro @MondayNightIBD @AmerGastroAssn @AASLDtweets 2) Concern that they are at increased risk for COVID-19. Impact of Medications on COVID-19 Outcomes in Inflammatory Bowel Disease: Analysis of More Than 6000 Patie…

RT @DocViswanathan: Research letter on impact of #ibd 💊 on #covid outcomes based on the #secure-ibd database. Take home point is that many…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 32 additional X posts.